Perspective Therapeutics, Inc. — Director's Dealing 2016

Jun 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-06-21

Reporting Person: Hoffmann Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-21	Stock Option (Right to Buy)	$0.93	A	25000	Acquired	2026-06-20	Common Stock (25000)	Direct

Footnotes

F1: (1) Will fully vest immediately.